Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
53.29
+0.04 (0.08%)
May 14, 2026, 9:42 AM EDT - Market open
Royalty Pharma Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$55.17
Upside
+3.53%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $50 → $66 | Strong Buy | Maintains | $50 → $66 | +23.85% | May 7, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $50 → $58 | Buy | Maintains | $50 → $58 | +8.84% | May 7, 2026 |
| UBS | UBS | Strong Buy Maintains $51 → $57 | Strong Buy | Maintains | $51 → $57 | +6.96% | Apr 21, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $61 → $63 | Buy | Maintains | $61 → $63 | +18.22% | Apr 10, 2026 |
| UBS | UBS | Hold → Strong Buy Upgrades $38 → $49 | Hold → Strong Buy | Upgrades | $38 → $49 | -8.05% | Jan 30, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $48 → $50 | Strong Buy | Maintains | $48 → $50 | -6.17% | Jan 27, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $42 → $45 | Strong Buy | Maintains | $42 → $45 | -15.56% | Dec 11, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $55 → $54 | Buy | Maintains | $55 → $54 | +1.33% | Oct 10, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | -21.19% | Sep 30, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $40 → $42 | Strong Buy | Maintains | $40 → $42 | -21.19% | Jul 22, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $51 → $54 | Buy | Maintains | $51 → $54 | +1.33% | Jul 10, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $60 → $40 | Strong Buy | Maintains | $60 → $40 | -24.94% | Oct 25, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $50 → $51 | Strong Buy | Maintains | $50 → $51 | -4.30% | Aug 14, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $48 → $51 | Buy | Maintains | $48 → $51 | -4.30% | Jul 11, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades $28 | Strong Buy → Hold | Downgrades | $28 | -47.46% | Jun 3, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $40 → $38 | Strong Buy | Maintains | $40 → $38 | -28.69% | Apr 12, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.